Davion Healthcare Plc. (NASDAQ:DAVI – Get Free Report) Director Julian Sluyters bought 25,000 shares of the company’s stock in a transaction on Monday, November 16th. The stock was bought at an average cost of $1.06 per share, for a total transaction of $26,500.00. Following the completion of the transaction, the director directly owned 30,000 shares of the company’s stock, valued at $31,800. This trade represents a 500.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Davion Healthcare Price Performance
DAVI stock opened at $1.02 on Tuesday. Davion Healthcare Plc. has a 1 year low of $0.91 and a 1 year high of $12.30.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded shares of Davion Healthcare to a “hold” rating in a research report on Saturday, October 31st.
Read Our Latest Analysis on Davion Healthcare
About Davion Healthcare
Davion Healthcare Plc is a digital healthcare company developing proprietary, non-invasive health monitoring technologies designed to support the early identification of medical anomalies outside traditional clinical environments. The Company’s flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. Davion Healthcare Plc is based in DUBLIN.
Featured Articles
- Five stocks we like better than Davion Healthcare
- Tyson Foods’ 10% Surge Puts a Breakout in Sight, But Wall Street Remains Cautious
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
Receive News & Ratings for Davion Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davion Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
